Search
for
Sort by
Research 31–60 of 509
- Incidence of acneform reactions after laser hair removal
- Sorafenib-Associated Facial Acneiform Eruption
- Concomitant occurrence of acneiform eruption, alopecia areata, and urticaria during adalimumab treatment in a patient with pustulosis palmoplantaris: Case report and literature review
- Cyclophosphamide-associated acneiform drug eruption in a patient with multiple myeloma
- A Sterile Folliculocentric Acneiform Eruption Mimicking Infection After Hair Transplantation: Clinical Pattern Recognition and a Proposed FUE Epidermal Cap–Angle Mechanism
- Toxic Side Effects of Targeted Therapies and Immunotherapies Affecting the Skin, Oral Mucosa, Hair, and Nails
- Cutaneous manifestations of dabrafenib (GSK2118436): a selective inhibitor of mutant BRAF in patients with metastatic melanoma
- Classification and management of skin, hair, nail and mucosal side-effects of epidermal growth factor receptor (EGFR) inhibitors
- Cutaneous Side Effects in Non-Small Cell Lung Cancer Patients Treated with Iressa (ZD1839), an Inhibitor of Epidermal Growth Factor
- Drug-Induced Skin, Nail and Hair Disorders
- Epidermal Growth Factor Receptor Inhibitors: A Review of Cutaneous Adverse Events and Management
- Lithium therapy associated with hidradenitis suppurativa: Case report and a review of the dermatologic side effects of lithium
- Drug-induced acne
- Dermatological side effects of epidermal growth factor receptor inhibitors: ′Pride′ complex
- Cutaneous side-effects of EGFR inhibitors and their management.
- Incidence and management of cutaneous toxicities associated with cetuximab
- Tofacitinib (Selective Janus Kinase Inhibitor 1 and 3): A promising therapy for the treatment of alopecia areata: A case report of six patients
- Taiwanese Dermatological Association consensus for the prevention and management of epidermal growth factor receptor tyrosine kinase inhibitor-related skin toxicities
- Mucocutaneous manifestations of acquired hypoparathyroidism: An observational study
- Skin toxicity of anti‐cancer therapy
- Difficult and rare forms of acne
- Adverse events of non-ablative fractional laser photothermolysis: a retrospective study of 856 treatments in 362 patients
- Patients with bullous skin disease in a high‐epidemic COVID‐19 area, Bergamo, Italy
- Clinical experiences on alopecia areata treatment with tofacitinib: A study of 63 patients
- Perifollicular Xanthomas Associated with Epidermal Growth Factor Receptor Inhibitor Therapy
- Cutaneous reactions to targeted therapies in children with CNS tumors: A cross‐sectional study
- Dermatologic Effects of Selumetinib in Pediatric Patients with Neurofibromatosis Type 1: Clinical Challenges and Therapeutic Management
- Prophylaxis and Management of Skin Toxicities
- Dermatologic Reactions to Targeted Therapy
- Cutaneous Toxicities From Transplantation-Related Medications